Form 4: Natera CEO Steven Chapman Reports RSU Vesting and Tax-Related Stock Sale

Natera, Inc. CEO Steven Chapman reported the vesting of 3,386 Restricted Stock Units and a subsequent sale of 1,622 shares to cover tax obligations.

Summary

• Steven Leonard Chapman, CEO and President, Director, and 10% Owner of Natera, Inc. (NTRA), reported transactions.
• On July 20, 2025, 3,386 Restricted Stock Units (RSUs) vested, converting into 3,386 shares of Natera Common Stock.
• On July 21, 2025, Mr. Chapman sold 1,622 shares of Natera Common Stock at a price of $139.29 per share.
• The sale was conducted to satisfy tax withholding and remittance obligations related to the RSU vesting and was executed under a Rule 10b5-1 trading plan.
• Following these transactions, Mr. Chapman directly beneficially owns 175,492 shares of Natera Common Stock.
• Mr. Chapman also holds 6,772 unvested Restricted Stock Units.

Sentiment

Score: 6

Explanation: The transaction is largely neutral as it's a routine tax-related sale following RSU vesting. The vesting itself is positive for executive retention, while the sale is a necessary consequence of that vesting. The 10b5-1 plan indicates good governance.

Positives

• Vesting of 3,386 Restricted Stock Units indicates continued compensation and retention of the CEO.
• The sale was explicitly for tax withholding, indicating a routine, non-discretionary transaction.
• The transaction was made pursuant to a Rule 10b5-1 plan, demonstrating pre-planned and compliant insider trading.

Negatives

• Sale of 1,622 shares, even for tax purposes, reduces the CEO's direct shareholding.

Future Outlook

The remaining 6,772 Restricted Stock Units held by the CEO are scheduled to vest in 12 equal quarterly installments, indicating a structured long-term incentive plan.

Industry Context

This filing represents a routine insider transaction for tax purposes, common across all industries for executives receiving equity compensation. It does not reflect broader industry trends or competitive positioning.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a form of executive compensation and the subsequent sale of shares to cover tax obligations are standard practices in publicly traded companies, particularly within the biotechnology and diagnostics sectors where Natera operates.
• The execution of the sale under a Rule 10b5-1 plan aligns with best practices for insider trading compliance, similar to how executives at companies like Illumina or Guardant Health manage their equity compensation.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor, routine reduction in CEO's direct shareholding due to tax obligations, offset by continued equity incentive alignment.
• Employees: No direct impact.
• Customers/Suppliers/Creditors: No direct impact.

Next Steps

• Remaining 6,772 Restricted Stock Units will vest in 12 equal quarterly installments.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned transaction by the CEO to cover tax obligations arising from RSU vesting. It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The transaction is a standard part of executive compensation and compliance, thus maintaining a 'hold' stance is appropriate as it neither significantly enhances nor detracts from the investment thesis.

Keywords

Natera, NTRA, Steven Chapman, CEO, Insider Trading, Form 4, Restricted Stock Units, RSU Vesting, Stock Sale, Tax Withholding, 10b5-1 Plan, Corporate Governance